Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

A boy with Sjogren-Larsson syndrome has skin and muscle symptoms due to a specific enzyme deficiency.

Women with AGA have higher lipid levels, increasing heart disease risk.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

The lotion and shampoo effectively treated scalp seborrheic dermatitis.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

New drugs are improving treatment for hormone-related diseases in small pets.

Hodgkin's lymphoma can show up as hair loss.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.